Earticle

현재 위치 Home

The Cost-Utility Analysis of a Chronic Disease Management Program for Patients with Hypertension and Diabetes in Korea

첫 페이지 보기
  • 발행기관
    한국보건사회약료경영학회 바로가기
  • 간행물
    한국보건사회약료경영학회지 바로가기
  • 통권
    Volume7 Number2 (2019.11)바로가기
  • 페이지
    pp.86-93
  • 저자
    Namhyun Kim, Minyoung Kim, Eunsol Seo, Sinyoung Jo, Eun Cho
  • 언어
    영어(ENG)
  • URL
    https://www.earticle.net/Article/A365147

※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

원문정보

초록

영어
BACKGROUND AND OBJECTIVE The quality of life (QoL) of patients with chronic disease could be lowered by the lack of their education and limited understanding about the treatment and disease. QoL is important for the treatment success because low QoL may negatively affect patients’ treatment or drug adherence. Thus, the “Chronic Disease Management (CDM)” program was implemented to help patients improve their QoL and treatment adherence in Korea. This study was aimed to evaluate the cost-utility outcome of a hypothetical CDM program for hypertension and diabetes patients. METHOD We conducted cost-utility analysis of the CDM program for both the registered and non-registered groups at baseline, 1-, 4- and 10-year follow ups with a limited social perspective. The costs for operating CDM program and direct/indirect medical cost were discounted at 5%. The main outcome measure was incremental cost-utility ratio (ICUR). Sensitivity analyses for discount rate were performed to assess the robustness of the results. RESULTS The CDM program increased patients’ QALYs by 0.044 per patient (from 0.902 to 0.946). The incremental cost was 237,431 won per person and the ICUR was 2,762,950 won/QALY. In addition, when the ICUR is calculated by reflecting the reduction cost for 10 years after the completion of CDM program, the ICUR becomes negative from 4 years later. ICUR/GDP is 0.29 at the first year of CDM program. DISCUSSION AND CONCLUSION This study showed that the CDM program could be cost-effective for patients with hypertension and diabetes. We suggest the current CDM program to be expanded in Korea.

목차

Abstract
Introduction
Method
1. Study design
2. Data and Assumptions
3. Study population
4. Cost Data
5. Cost-Utility Analysis
6. Time Preference and Sensitivity Analysis
Results
1. Effect
2. Cost
3. Incremental Cost-Utility Ratio (ICUR)
4. Sensitivity analysis
Discussion and Conclusion
Acknowledgement
References

키워드

Chronic disease management Cost-utility analysis Hypertension Diabetes Korea

저자

  • Namhyun Kim [ College of Pharmacy, Sookmyung Women’s University, Seoul, South Korea. ]
  • Minyoung Kim [ College of Pharmacy, Sookmyung Women’s University, Seoul, South Korea. ]
  • Eunsol Seo [ College of Pharmacy, Sookmyung Women’s University, Seoul, South Korea. ]
  • Sinyoung Jo [ College of Pharmacy, Sookmyung Women’s University, Seoul, South Korea. ]
  • Eun Cho [ College of Pharmacy, Sookmyung Women’s University, Seoul, South Korea. ] Corresponding Author

참고문헌

자료제공 : 네이버학술정보

간행물 정보

발행기관

  • 발행기관명
    한국보건사회약료경영학회 [Korean Academy of Social & Managed Care Phemacy]
  • 설립연도
    2009
  • 분야
    의약학>약학
  • 소개
    본 학회는 비영리 학술단체로서 환자의 삶의 질 향상을 위한 약료(pharmaceutical care)가 보장될 수 있도록 약료경영약학(managed care pharmacy)을 발전시키는 데 궁극 목적을 두고 다음과 같은 활동을 전개하여 사회에 기여하며 회원 상호간의 친목을 도모한다.

간행물

  • 간행물명
    한국보건사회약료경영학회지 [Journal of Korean Academy of Managed Care Pharmacy]
  • 간기
    반년간
  • pISSN
    2092-8394
  • 수록기간
    2009~2022
  • 십진분류
    KDC 518 DDC 615

이 권호 내 다른 논문 / 한국보건사회약료경영학회지 Volume7 Number2

    피인용수 : 0건 (자료제공 : 네이버학술정보)

    함께 이용한 논문 이 논문을 다운로드한 분들이 이용한 다른 논문입니다.

      출처 : 네이버학술정보

        0개의 논문이 장바구니에 담겼습니다.

        페이지 저장
        소속기관 조회
        이용자님의 소속기관(단체)이 서비스에 가입되어 있는지 확인해 보십시오.
        기관회원에 소속되어 있는 이용자는 원문을 무료로 이용할 수 있습니다.